Cancer Immunotherapy Market Latest Research, Growth, Trends, Absolute Opportunity and Value Chain 2018-2023
Cancer immunotherapy is the use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid. These approaches exploit the fact that cancer cells often have molecules on their surface that can be detected by the immune system, known as tumour-associated antigens; they are often proteins or other macromolecules. Active immunotherapy directs the immune system to attack tumor cells by targeting TAAs. Passive immunotherapies enhance existing anti-tumor responses and include the use of monoclonal antibodies,...
View full press release